Company
Tiziana Life Sciences Ltd (TLSA)
Standardized SEC financial data for Tiziana Life Sciences Ltd — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001723069 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-301.4%
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| R&D expense | $3.7M | $6.0M | $13.2M | $13.0M | $8.1M | $5.2M |
| Net income | -$9.3M | -$26.1M | -$23.4M | -$15.4M | -$17.7M | -$11.9M |
Standardized from Tiziana Life Sciences Ltd's SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Total assets | $2.4M | $70.7M | $48.8M | $26.5M | $12.2M | $11.3M |
| Total liabilities |
Get TLSA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/TLSA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/TLSA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"